---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-117745"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2026-03-20T23:59:59+00:00"
generated_at: "2026-05-15T09:27:37.283834+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# EyePoint files defamation lawsuit against Ocular Therapeutix over false statements about DURAVYU

## Summary
- Complaint filed March 20, 2026 in Middlesex County Superior Court (Massachusetts).
- Alleges Ocular Therapeutix made false/misleading representations about EyePoint's lead product DURAVYU (vorolanib intravitreal insert).
- Claims include defamation, commercial disparagement, violation of Mass. Gen. L. c. 93A, and tortious interference.
- Seeks injunctive relief, public retraction, monetary damages, attorneys' fees, and other relief.
- EyePoint asserts defendant's actions harmed its business relations and clinical results reputation.

## SEC filing metadata
- accession: 0001193125-26-117745
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2026-03-20T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000119312526117745/0001193125-26-117745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000119312526117745/eypt-20260320.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-117745
- JSON: https://secwatch.observer/filing/0001193125-26-117745.json
- Plain text: https://secwatch.observer/filing/0001193125-26-117745.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.